JULY/AUGUST

Vol 10, No 4 CME Pretest

This Journal provides 4 hours of Category 1 Continuing Medical Education

Complimentary CME Credits

Physicians can earn 4 credit hours of Category 1 for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions in the posttest at the end of this issue. Complete instructions are given on the posttest pages. Successfully answering 30 or more questions will earn 4 credit hours.

Educational Objectives

After reading this issue of Cancer Control, clinicians will be expected to:

• describe the various approaches to enhance the local control of small-cell and non–small-cell lung cancer,
  
  
• apply current knowledge on secondary prevention of lung cancer as well as primary chemoprevention and smoking cessation, and
  
  
• understand the major mechanisms of resistance to cisplatin.

This program was planned in accordance with ACCME Essentials.

Release Date: July 1, 2003
Expiration Date: July 1, 2004

1. If supraclavicular nodes are not radiated prophylactically when radiation is given as treatment for lung cancer, what is the approximate incidence of tumor spread to them?

a. 5%
b. 10%
c. 20%
d. 30%

2. A meta-analysis of trials of patients with small-cell lung cancer (SCLC) in complete remission after therapy showed that prophylactic cranial irradiation produced what change in survival at 3 years?

a. increased by 8%
b. increased by 5%
c. no effect on survival
d. decreased by 5%

3. In cancer patients who have quit smoking, relapse to smoking is most likely at what period after hospitalization?

a. first month
b. 1 to 2 months
c. 3 to 6 months
d. 7 to 12 months